Search

everythinglearnresearchcommunity

for

Search:↓

Efalizumab can cause unexpected excessive hair growth.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Mirtazapine can cause male breast enlargement.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Tofacitinib may help treat severe hair loss, but more research is needed.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Pranlukast and mirabegron may work as new diabetes drugs.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.